Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Xcelience, Penn Pharma Form API JV | Contract Pharma
Breaking News, Collaborations & Alliances

Xcelience, Penn Pharma Form API JV

Penn Pharma and Xcelience, LLC have entered into a joint venture agreement to provide Capsugel’s Xcelodose precision powder micro-dosing system technology on a global basis.

Penn Pharma and Xcelience, LLC have entered into a joint venture agreement to provide Capsugel’s Xcelodose precision powder micro-dosing system technology on a global basis. Xcelodose is a registered trademark of Capsugel, a division of Pfizer.

The JV aims to provide pharma and biopharma companies with the opportunity to manufacture first in human batches faster and closer to clinical sites. The companies will operate on the network of Xcelodose systems worldwide, which is designed to guarantee immediate manufacturing capacity.

“This joint venture will create a powerful partnership between two leading providers who share a common commitment to quality, innovation, and building client relationships based on trust and performance,” said Derek Hennecke, chief executive officer and president of Xcelience. “Xcelience has more than six years experience in powder in capsule technology and has processed more than 100 clinical supply batches using the Xcelodose technology,” notes Paul Wituschek, Global Sales & Marketing Director of Penn. “Penn will be able to immediately leverage this expertise to provide this important accelerated development option to our clients.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters